BioInvent International AB (LTS:0H22) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 12, 2026)


LTS:0H22 BioInvent International AB LTS:0H22
42 GF Score
Price kr23.40
GF Value kr50.35
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioInvent International AB Float Percentage Of Total Shares Outstanding?

BioInvent International AB LTS:0H22 +0.65% 42 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 12, 2026. GuruFocus rates LTS:0H22 with a GF Score™ of 42/100 and a GF Value™ of kr50.35 (Possible Value Trap). The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioInvent International AB's float shares is 0.00 Mil. BioInvent International AB's total shares outstanding is 65.80 Mil. BioInvent International AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioInvent International AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioInvent International AB's Institutional Ownership is 14.31%.

LTS:0H22
42GF Score
BioInvent International AB LTS:0H22
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioInvent International AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BioInvent International AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/65.80
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
BioInvent International AB (LTS:0H22) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 12, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BioInvent International AB and its competitors.
Is BioInvent International AB's Float Percentage Of Total Shares Outstanding too high?
BioInvent International AB's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, BioInvent International AB has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioInvent International AB's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
BioInvent International AB's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BioInvent International AB and its competitors. BioInvent International AB's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioInvent International AB stock overvalued right now?
Based on GuruFocus' analysis, BioInvent International AB (LTS:0H22) is currently considered Possible Value Trap. The stock's GF Value™ is kr50.35, compared to a current price of kr23.40 — trading 53.5% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. BioInvent International AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For BioInvent International AB (LTS:0H22), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioInvent International AB (LTS:0H22) Overvalued in 2026?

Based on GuruFocus' analysis, BioInvent International AB stock appears to be undervalued. The current stock price of kr23.40 is trading 53.5% below its estimated GF Value™ of kr50.35. GuruFocus considers BioInvent International AB to be Possible Value Trap.

Key valuation signals for LTS:0H22:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: kr50.35 vs. price of kr23.40 (53.5% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the LTS:0H22 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioInvent International AB Business Description

Other Exchanges BINV:SwedenBIX:Germany
Address Ideongatan 1, Lund, SWE, SE-223 70
BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.
42GF Score

Get the complete analysis for LTS:0H22

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr23.40
Price
kr50.35
GF Value